Overview
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 24 days early. All were audited by a statutory auditor.
- 202515/06/2026
- 202429/05/2025
- 202326/06/2024
- 202229/06/2023
- 202106/07/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Public procurement
332 tenders recorded as contractor: 169 national ($5,030,685) and 163 EU ($18,869,051).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 26, 2026 | Supply of scientific and research equipment for the units of Uniwersytet Przyrodniczy w Lublinie, divided into 18 lots. | $15,951$15,951 | Uniwersytet Przyrodniczy w Lublinie | |
| Oct 22, 2026 | Delivery of laboratory reagents and small laboratory equipment, together with the lease of a real-time PCR instrument | $55,400$55,400 | Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie | |
| Oct 20, 2026 | Supply of laboratory reagents and diagnostic tests – 3rd procedure | –– | Wojewódzka Stacja Sanitarno-Epidemiologiczna w Kielcach |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krystyna Kamińskaage 66 | 490 | $6,618.04 | 49% |
Tomasz Mieczysław Kamińskiage 75 | 500 | $6,753.11 | 50% |
Others | 10 | $135.06 | 1% |
Tomasz Mieczysław Kamiński and Krystyna Kamińska hold a combined 99% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
TK Biotech Technologysp. z o.o. | 1,350.62 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2016-03-08.
25 1030 1508 0000 0008 1797 5011- 28 1030 1508 0000 0008 1797 5054
- 72 1030 1508 0000 0008 1797 5038
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 26, 2022 | Call to creditors |
Public aid
5 public aid cases recorded, with a total value of $71,443.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 2, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| Biochem PolskaS.A. | $13,180,007.81 | biochempolska.pl | ||
| AO East Europesp. z o.o. | $13,998,610.57 | aoeasteurope.pl | ||
| PolypharmS.A. | $13,660,727.48 | polypharm.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| Billmedsp. z o.o. | $5,738,714.60 | e.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-21 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2022-09-19 | Share capital reduction (1,000,000.00 PLN → 50,000.00 PLN) | |
| 2021-06-11 | Entered in the register |
FAQ
Last updated: 2026-09-15